FR3055M - - Google Patents

Info

Publication number
FR3055M
FR3055M FR926309A FR926309A FR3055M FR 3055 M FR3055 M FR 3055M FR 926309 A FR926309 A FR 926309A FR 926309 A FR926309 A FR 926309A FR 3055 M FR3055 M FR 3055M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR926309A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of FR3055M publication Critical patent/FR3055M/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B11/00—Preservation of milk or dairy products
    • A23B11/10—Preservation of milk or milk preparations
    • A23B11/12—Preservation of milk or milk preparations by heating
    • A23B11/13—Preservation of milk or milk preparations by heating the materials being loose unpacked
    • A23B11/133—Preservation of milk or milk preparations by heating the materials being loose unpacked and progressively transported through the apparatus
    • A23B11/137—Preservation of milk or milk preparations by heating the materials being loose unpacked and progressively transported through the apparatus in direct contact with the heating medium, e.g. steam
    • A23B11/1375—Preservation of milk or milk preparations by heating the materials being loose unpacked and progressively transported through the apparatus in direct contact with the heating medium, e.g. steam by pulverisation of the milk, including free falling film
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR926309A 1962-01-10 1963-02-28 Active FR3055M (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US165298A US3156620A (en) 1962-01-10 1962-01-10 Attenuated live rabies vaccine and method of preparing the same
FR920463 1963-01-04

Publications (1)

Publication Number Publication Date
FR3055M true FR3055M (en:Method) 1965-01-11

Family

ID=22598325

Family Applications (2)

Application Number Title Priority Date Filing Date
FR1604109D Expired FR1604109A (en) 1962-01-10 1963-01-04 Live attenuated rabies vaccine is produced by culturing the virus in chick embryo tissue contng. 0.5-5% of a hydrolysed collagen deriv., such as gelatin, which
FR926309A Active FR3055M (en:Method) 1962-01-10 1963-02-28

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR1604109D Expired FR1604109A (en) 1962-01-10 1963-01-04 Live attenuated rabies vaccine is produced by culturing the virus in chick embryo tissue contng. 0.5-5% of a hydrolysed collagen deriv., such as gelatin, which

Country Status (5)

Country Link
US (1) US3156620A (en:Method)
BR (1) BR6345841D0 (en:Method)
CH (1) CH423095A (en:Method)
FR (2) FR1604109A (en:Method)
GB (1) GB958344A (en:Method)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3435117A (en) * 1966-03-09 1969-03-25 Ethicon Inc Collagen fibril matrix pharmaceuticals
US3469003A (en) * 1966-04-01 1969-09-23 Haver Lockhart Lab Inc Injectable reconstituted collagen fluid adjuvant for vaccines and other drugs
US4147772A (en) * 1976-02-03 1979-04-03 Merck & Co., Inc. Vaccine stabilizer
DE2816349A1 (de) * 1978-04-14 1979-10-25 Merck & Co Inc Vaccinstabilisator
CH638985A5 (de) * 1979-04-10 1983-10-31 Schweiz Serum & Impfinst Verfahren zur herstellung eines tollwutimpfstoffes und danach erhaltener impfstoff.
US4338335A (en) * 1980-02-05 1982-07-06 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
JPS5832876B2 (ja) * 1981-03-27 1983-07-15 呉羽化学工業株式会社 組織培養基材
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
JPS5928472A (ja) * 1982-08-09 1984-02-15 Koken:Kk 細胞培養用基質およびこの基質を用いた細胞培養・分離法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2773800A (en) * 1953-04-28 1956-12-11 Lilly Co Eli Rabies vaccine production
US2768114A (en) * 1953-08-21 1956-10-23 American Cyanamid Co Rabies vaccines and methods of preparing the same
US2915436A (en) * 1955-04-11 1959-12-01 Allied Lab Inc Process for the attenuation of infectious canine hepatitis virus and a vaccine prepared therefrom
US2912361A (en) * 1956-11-28 1959-11-10 Sterling Drug Inc Canine distemper vaccine and its preparation
US3000788A (en) * 1958-05-15 1961-09-19 Dow Chemical Co Propagation of modified infectious canine hepatitis virus in tissue cultures of pig kidney and the preparation of a vaccine therefrom
US2965544A (en) * 1959-02-24 1960-12-20 American Cyanamid Co Tissue culture propagated canine distemper virus and vaccine thereof

Also Published As

Publication number Publication date
FR1604109A (en) 1971-07-12
US3156620A (en) 1964-11-10
GB958344A (en) 1964-05-21
BR6345841D0 (pt) 1973-06-14
CH423095A (de) 1966-10-31

Similar Documents

Publication Publication Date Title
FR3055M (en:Method)
BE616548R (en:Method)
BE623092A (en:Method)
BE624833A (en:Method)
BE538831A (en:Method)
BE630969A (en:Method)
BE630285A (en:Method)
BE629958A (en:Method)
BE559145A (en:Method)
BE612926A (en:Method)
BE629288A (en:Method)
BE628823A (en:Method)
BE628597A (en:Method)
BE613298A (en:Method)
BE627249A (en:Method)
BE626042A (en:Method)
CH1348462A4 (en:Method)
BE613529A (en:Method)
BE638363A (en:Method)
BE632172A (en:Method)
BE615804A (en:Method)
BE616904A (en:Method)
BE617546A (en:Method)
BE627451A (en:Method)
BE626905A (en:Method)